Skip to main content
. 2021 Aug 14;107(1):e315–e327. doi: 10.1210/clinem/dgab596

Table 3.

Selected models for the prediction of birthweight

Models Difference in birthweight (SDS) (95% CI) Adjusted R2 (%) SD of the residuals
BMI modela
 Prepregnancy BMI 0.03 (0.00; 0.05) 6.1 0.93
Biomarker modelb
 Prepregnancy BMI 0.02 (0.00; 0.04) 6.2 0.93
 Glucose 0.06 (-0.01; 0.14)
 Triglycerides 0.01 (-0.07; 0.05)
 HDL-cholesterol -0.03 (-0.11; 0.05)
 Metabolite modelc
 Prepregnancy BMI 0.05 (0.03; 0.07) 12.9 0.90
 Gln 0.03 (-0.05; 0.13)
 Lys -0.04 (-0.12; 0.04)
 NEFA.18:2 0.08 (-0.04; 0.19)
 NEFA.20:3 0.06 (-0.06; 0.18)
 NEFA.22:3 -0.15 (-0.26; -0.05)
 PC.aa.C30:0 0.05 (-0.04; 0.15)
 PC.aa.C38:3 0.14 (0.00; 0.27)
 PC.ae.C34:4 -0.14 (-0.24; -0.05)
 Lyso.PC.a.C16:1 -0.23 (-0.33; -0.12)
 Lyso.PC.a.C20:4 0.04 (-0.07; 0.14)
 SM.a.C36:1 -0.05 (-0.22; 0.12)
 SM.a.C36:2 -0.15 (-0.34; 0.04)
 SM.a.C40:2 0.13 (0.01; 0.25)
 SM.a.C42:4 0.12 (-0.01; 0.26)
 Carn.a.C10:1 -0.09 (-0.18; 0.00)
 Asn/Asp ratio 0.03 (-0.05; 0.11)
 Gln/Glu ratio 0.03 (-0.06; 0.12)
 NEFA.16:1/16:0 ratio -0.06 (-0.13; 0.01)
 ΣPC.aa/ΣPC.ae ratio -0.01 (-0.10; 0.07)

Values represent regression coefficients (95% CI) and adjusted R2 obtained from linear regression models.

Abbreviations: Asn/Asp, asparagine/aspartic acid; BMI, body mass index; Gln/Glu, glutamine/glutamic acid; HDL, high-density lipoprotein; SDS, SD score.

aBMI model includes maternal prepregnancy BMI, gestational age at blood sampling, age, educational level, parity, smoking, alcohol consumption, folic acid supplementation, daily total energy intake, systolic blood pressure, and fetal sex.

bBiomarker model includes the BMI model with additional adjustment for maternal glucose, triglycideride, and HDL-cholesterol concentrations

cMetabolite model includes the BMI model with additional adjustment for selected maternal early-pregnancy metabolites.